153 related articles for article (PubMed ID: 9537577)
1. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix.
Yoshino K; Enomoto T; Nakamura T; Nakashima R; Wada H; Saitoh J; Noda K; Murata Y
Int J Cancer; 1998 Apr; 76(2):176-81. PubMed ID: 9537577
[TBL] [Abstract][Full Text] [Related]
2. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
[TBL] [Abstract][Full Text] [Related]
3. Analysis of FHIT transcripts in cervical and endometrial cancers.
Su TH; Wang JC; Tseng HH; Chang CP; Chang TA; Wei HJ; Chang JG
Int J Cancer; 1998 Apr; 76(2):216-22. PubMed ID: 9537583
[TBL] [Abstract][Full Text] [Related]
4. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
[TBL] [Abstract][Full Text] [Related]
5. FHIT alterations in cancerous and non-cancerous cervical epithelium.
Yoshino K; Enomoto T; Nakamura T; Sun H; Ozaki K; Nakashima R; Wada H; Saitoh J; Watanabe Y; Noda K; Murata Y
Int J Cancer; 2000 Jan; 85(1):6-13. PubMed ID: 10585575
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas.
Herzog CR; Crist KA; Sabourin CL; Kelloff GJ; Boone CW; Stoner GD; You M
Mol Carcinog; 2001 Mar; 30(3):159-68. PubMed ID: 11301476
[TBL] [Abstract][Full Text] [Related]
7. FHIT (fragile histidine triad) gene analysis in cervical intraepithelial neoplasia.
Liu FS; Hsieh YT; Chen JT; Ho ES; Hung MJ; Lin AJ
Gynecol Oncol; 2001 Aug; 82(2):283-90. PubMed ID: 11531281
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type.
Muller CY; O'Boyle JD; Fong KM; Wistuba II; Biesterveld E; Ahmadian M; Miller DS; Gazdar AF; Minna JD
J Natl Cancer Inst; 1998 Mar; 90(6):433-9. PubMed ID: 9521167
[TBL] [Abstract][Full Text] [Related]
9. fhit Alterations in endometrial carcinoma and hyperplasia.
Ozaki K; Enomoto T; Yoshino K; Hongbo S; Nakamura T; Fujita M; Kuragaki C; Sakata M; Kurachi H; Murata Y
Int J Cancer; 2000 Feb; 85(3):306-12. PubMed ID: 10652418
[TBL] [Abstract][Full Text] [Related]
10. HPV-associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA.
Chu TY; Shen CY; Chiou YS; Lu JJ; Perng CL; Yu MS; Liu HS
Int J Cancer; 1998 Jan; 75(2):199-204. PubMed ID: 9462708
[TBL] [Abstract][Full Text] [Related]
11. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer.
Holschneider CH; Baldwin RL; Tumber K; Aoyama C; Karlan BY
Clin Cancer Res; 2005 Aug; 11(16):5756-63. PubMed ID: 16115913
[TBL] [Abstract][Full Text] [Related]
12. Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.
Connolly DC; Greenspan DL; Wu R; Ren X; Dunn RL; Shah KV; Jones RW; Bosch FX; Muñoz N; Cho KR
Clin Cancer Res; 2000 Sep; 6(9):3505-10. PubMed ID: 10999736
[TBL] [Abstract][Full Text] [Related]
13. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
[TBL] [Abstract][Full Text] [Related]
14. Anomalous transcripts and allelic deletions of the FHIT gene in human esophageal cancer.
Menin C; Santacatterina M; Zambon A; Montagna M; Parenti A; Ruol A; D'Andrea E
Cancer Genet Cytogenet; 2000 May; 119(1):56-61. PubMed ID: 10812172
[TBL] [Abstract][Full Text] [Related]
15. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines.
Hendricks DT; Taylor R; Reed M; Birrer MJ
Cancer Res; 1997 Jun; 57(11):2112-5. PubMed ID: 9187105
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features.
Butler D; Collins C; Mabruk M; Barry Walsh C; Leader MB; Kay EW
J Pathol; 2000 Dec; 192(4):502-10. PubMed ID: 11113868
[TBL] [Abstract][Full Text] [Related]
17. Expression of abnormal transcripts of the FHIT (fragile histidine triad) gene in ovarian carcinoma.
Mandai M; Konishi I; Kuroda H; Nanbu K; Matsushita K; Yura Y; Hamid AA; Mori T
Eur J Cancer; 1998 Apr; 34(5):745-9. PubMed ID: 9713284
[TBL] [Abstract][Full Text] [Related]
18. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines.
Mao L; Fan YH; Lotan R; Hong WK
Cancer Res; 1996 Nov; 56(22):5128-31. PubMed ID: 8912845
[TBL] [Abstract][Full Text] [Related]
19. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
20. Expression of truncated FHIT transcripts in cervical cancers and in normal human cells.
Matthews CP; Shera K; Kiviat N; McDougall JK
Oncogene; 2001 Aug; 20(34):4665-75. PubMed ID: 11498789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]